JBJitendriya Biswal

Jitendriya Biswal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jitendriya Biswal has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Randomised Controlled Trial on the Efficacy of Ketamine versus Electroconvulsive Therapy in Severe Depression with Suicidal Ideation

    by Lavanya Seth, Jitendriya Biswal, Surjeet Sahoo, Riya Shetty, Jamuna Das

    Introduction: Severe depressive episodes with suicidal ideation present major therapeutic challenges and often require interventions beyond standard antidepressant therapy. Electroconvulsive therapy (ECT) remains a cornerstone treatment for refractory depression, while ketamine, an N-methyl-D-aspartate receptor antagonist, has emerged as a rapid-acting antidepressant with potential benefits in reducing suicidal ideation. This study compares the efficacy, onset of action, and tolerability of intravenous ketamine and ECT as adjunctive treatments in severe major depressive disorder with active suicidal ideation. Methods: A randomised controlled trial was conducted at a tertiary care psychiatry department in India, enrolling 64 patients aged 18–60 years with severe depression (HAM-D ≥19, SSI ≥4). Participants were randomly assigned to receive either intravenous ketamine (n = 31) or ECT (n = 33), alongside ongoing oral antidepressants. Both groups underwent six treatment sessions over 2 weeks. Outcomes were assessed at baseline, post-treatment, and 4 weeks after completion. Primary endpoints included changes in depression severity (HAM-D) and suicidal ideation (SSI), while secondary outcomes included response and remission rates, as well as safety and tolerability profiles. Results: Both ECT and ketamine significantly reduced depressive symptoms and suicidal ideation (p < 0.001). HAM-D scores declined from 27 to 1 in the ECT group and from 26 to 2 in the ketamine group by the 4-week follow-up. SSI scores showed parallel improvement, from 12.1 to 1.2 with ECT and 12.6 to 2.0 with ketamine. Ketamine demonstrated a faster onset of clinical improvement, while ECT showed slightly greater durability of response. Side effects were mild in both groups, though ECT was associated with transient cognitive impairment, whereas ketamine produced minor dissociative and urinary symptoms. Conclusion: Ketamine offers a faster reduction in suicidal ideation than ECT, making it a promising acute intervention. Both are effective, safe adjunctive therapies, with treatment choice guided by patient profile and tolerability.


  • A Study on The Psychological Determinants of Substance Use among Indian ‎University Students Diagnosed with Borderline Personality Disorder

    by Jamuna Das, Jitendriya Biswal, Rakesh Mohanty

    Background: Borderline personality disorder (BPD) frequently co-occurs with substance use, yet ‎the psychological mechanisms underlying this relationship remain insufficiently understood. This ‎study examines the association between BPD and substance use, with a focus on impulsivity, ‎emotional dysregulation, anxiety, and depression.‎ Method: A cross-sectional study was conducted between September 2023 and December 2024 ‎among undergraduate students from multiple institutions within a single university in Eastern ‎Odisha. Substance use was assessed using the Alcohol, Smoking, and Substance Involvement ‎Screening Test (ASSIST, Version 3). Psychological constructs were measured using the Difficulties ‎in Emotion Regulation Scale, Barratt Impulsiveness Scale, and Hamilton Depression and Anxiety ‎Rating Scales (HAM-D, HAM-A).‎ Results: Of the total participants, 5.8% (N = 115) met criteria for BPD, and 37.3% (N = 43) of ‎these reported substance use. Cannabis (81.4%) and tobacco (60.5%) were the most commonly used ‎substances among individuals with BPD, whereas alcohol, opioids, sedatives, inhalants, and other ‎drugs showed lower prevalence. Psychological symptoms were highly prevalent in the BPD group, ‎including impulsivity (62.6%), emotional dysregulation (67.9%), anxiety (53.1%), and depression ‎‎(34.8%). Substance use demonstrated strong associations with anxiety (χ² = 20.786, OR = 10.307, p ‎‎< 0.001), emotional dysregulation (χ² = 8.196, OR = 4.296, p = 0.004), and impulsivity (χ² = 12.624, ‎OR = 6.576, p < 0.001). In contrast, depression was not significantly associated with substance use ‎‎(p = 0.409). ‎ Conclusion: Adults with BPD exhibit significantly higher rates of substance use, particularly ‎cannabis and tobacco, compared to their non-BPD counterparts. Psychological factors, especially ‎impulsivity, emotional dysregulation, and anxiety, emerged as strong predictors of substance-use ‎vulnerability, whereas depression did not show a significant association‎.

  • Open Access

    ADHD Co-Occurring Conditions: A Multidisciplinary Approach

    by Jamuna Das, Jitendriya Biswal

    Attention-deficit/hyperactivity disorder (ADHD) rarely manifests itself in isolation as a straightforward clinical syndrome but rather occurs in a mixture of clinically relevant neurodevelopmental, psychiatric, and somatic comorbidities. The heterogeneous manifestation of phenotypic forms highlights the interdisciplinarity of the methods involved, necessitating an integrated approach that draws from medical, psychological, educational, and sociocultural perspectives. It is this view of heterogeneity, or evidence of variability in clinical features of ADHD, that this chapter reflects upon. This chapter is primarily concerned with evidence-based interventions that facilitate the adoption of integrative diagnostic approaches and the implementation of multimodal treatment models. In the spirit of interdisciplinarity as well as individualized treatment models, this chapter aims to support a systems-based approach to ADHD that focuses on the maximization of function beyond symptom management and long-term adaptation. It supports integrated models of the multifactorial etiology of ADHD, as well as the psychosocial burden across the lifespan, while acknowledging the relevance of functional outcome assessment.


  • Open Access

    Exploring Emotional Regulation, Depression, Impulsivity, and Anxiety Connected to Attention Deficit Hyperactivity Disorder with Substance Use

    by Jamuna Das, Jitendriya Biswal, Rakesh Mohanty

    Background: Emotional regulation difficulties, depression, impulsivity, and anxiety are psychological factors that frequently co-occur with substance use in attention deficit hyperactivity disorder. These factors contribute to maladaptive coping strategies, increasing vulnerability to substance use patterns. Objective: To explore the psychological factors of the co-occurrence of ADHD with substance use, with a specific focus on emotional regulation, depression, impulsiveness, and anxiety. Methods: This cross-sectional study, conducted from September 2023 to September 2024 at a university in Eastern Odisha, explored psychological factors among undergraduate students aged 18–26 with ADHD and co-occurring substance use. Data collection utilizes validated tools, including ASRS-V1.1, ASSIST, HAM-D, HAM-A, DERS, and BIS. Results: The study analyzed 1,310 undergraduate students, showing 8.2% with ADHD, of which 52.3% reported substance use (SU). Impulsivity was significantly associated with SU, with higher impulsivity reported in SU individuals. Anxiety also showed a strong association with SU. However, emotional dysregulation and depression were not significantly linked to SU. These findings highlight key psychological factors influencing substance use in ADHD. Conclusions: This study underscores the significant role of impulsiveness and anxiety in the co-occurrence of substance use (SU) among individuals with ADHD, while emotional dysregulation and depression were not found to have a significant association. These findings highlight the need for targeted interventions addressing impulsiveness and anxiety to mitigate the risk of SU in this population.


  • Open Access

    Quality of Life Outcomes in Chronic Disease Management: A Leadership Perspective

    by Shardha Purohit, Dhruvin Chauhan, Jitendriya Biswal, Simranjeet Nanda, Bharat Bhushan, Pooja Varma, Bhupal Pujari

    Introduction:This study aimed to explore the perspectives of leaders in chronic disease management and the impact of their leadership practices on the quality of life outcomes for patients with chronic diseases.Methods:A sample of leaders working in chronic disease management were interviewed qualitatively, transcribed, and analyzed thematically. Results:Leaders identified several key ways in which their leadership practices influenced the quality of life outcomes for chronic disease patients. These included providing support and resources for patients, implementing multidisciplinary care teams, promoting patient empowerment and self-management, and fostering a culture of collaboration and continuous improvement. Leaders also recognized the importance of their well-being and self-care in effectively managing chronic diseases and promoting quality of life for patients. Conclusions:Leaders play a critical role in shaping the quality of life outcomes for patients with chronic diseases. By implementing effective leadership practices, such as providing support and resources, promoting self-management, and fostering collaboration, leaders can help improve the overall well-being of patients with chronic diseases. Moreover, leaders should prioritize their well-being and self-care in order to better support and lead their care teams and ultimately improve the quality of life for chronic disease patients. This study highlights the importance of leadership in chronic disease management and provides valuable insights for leaders to enhance their practices and ultimately improve patient outcomes.

  • Open Access

    Machine learning for Forecasting quality of life variations in hemodialysis patients

    by Jamuna Kv, Uma Bhardwaj, Jagdish Gohil, Jitendriya Biswal, Raj Nimesh, Lovish Dhingra, V. C. Patil

    Objective: To anticipate changes in quality of life (QoL) evaluations for hemodialysis patients. over the course of the following month and to use ML to establish an early warning system. Materials and methods: A hospital with a dialysis unit hosted the trial, which lasted one month and included an approaching group. Approximately 78 patients have been enrolled up to this date. Preformed including demographic information MBBS-degree holding medical professionals administered the validated WHO-BREF. It has to be done again on the same patient a month later by the same investigator. R and Orange were used for machine learning, while SPSS version 24 was used to provide basic statistics.Results: In order to predict whether a patient's WHO-QOL-BREF score would increase or decrease by 5% over the course of a month, two models were developed using ML methods. A 5% or greater loss in QOL scores occurs over the course of the next month as a result of declines in the psychosomatic, substantial, and societal domain scores.Conclusion: The Dialysis Data Interpretation for Algorithmic-Prediction on QOL early warning system based on ML was developed to identify quickly declining QOL scores in the hemdialysis sample. The model suggested that improving the psychological and ecological domains in exacting could be able to arrest the fall in QOL ratings. If DIAL is used more widely, it should benefit patients by guaranteeing a greater QOL and reducing the long-term cost burden.


  • Open Access

    Understanding Attention Deficit Hyperactivity Disorder: Prevalence, Etiology, Diagnosis, and Therapeutic Approaches

    by Jamuna Das, Jitendriya Biswal, Rakesh Mohanty, Manika Bose, Sansita Parida

    Background: Attention deficit hyperactivity disorder (ADHD) is classified using neoclassical systems such as the Diagnostic Statistical Manual of Mental Disorders-5 and the International Classification of Disease-10. There is significant evidence that pharmaceutical treatment, particularly stimulants, can reduce symptoms in the short term. Objective: To explore the comprehensive landscape of childhood to adulthood ADHD within the literature, which involves delving into its prevalence, etiology, risk factors, diagnosis, and treatment modalities. Methods: A literature search was conducted across articles published in English between 2011 and 2023; the literature extensively explored the prevalence, etiology, risk factors and diagnosis of the subject, with limited attention given to treatment between 2003 and 2023, utilizing electronic search engines such as Google Scholar, PubMed, IndMED, and MedIND, Scopus, and Web of Science. The search terms included "ADHD," "Attention Deficit and Hyperactivity Disorder," "Hyperactivity," "Child Psychiatry," "Hyperkinetic Disorder," "Attention Deficit Disorder," and "Worldwide.” Results: Out of the 400 papers evaluated, only 52 met the criteria encompassing prevalence, etiology, diagnosis, and treatment. Conclusions: ADHD is a prevalent neurodevelopmental disorder impacting individuals from childhood to adulthood, with varying prevalence rates globally. Methodological differences influence prevalence estimates, highlighting the need for standardized study designs. Both genetic and environmental factors contribute to its development. Management typically involves a combination of psychotherapy, lifestyle adjustments, and medication. However, refined diagnostic criteria and tailored treatment guidelines for children and adults are necessary. Continuous evaluation of interventions is crucial for optimizing care and enhancing the well-being of individuals with ADHD.


  • Open Access

    Impact of the COVID-19 Pandemic on the Mental Health of Medical Undergraduates of a Tertiary Care Teaching Hospital in Eastern Odisha: A Cross-Sectional Study

    by Manika Bose, Debasish Misra, Smita Das, Tapaswini Mishra, Jitendriya Biswal, Swati Mishra

    Background: The Corona virus pandemic had a crushing impact on the mental health of medical undergraduates. Objective: The current research was conducted to evaluate the prevalence of psychological impacts, viz., anxiety, stress, and depression, in undergraduates undertaking medicine courses and assess their quality of life. Methods: A prospective cross-sectional study was undertaken with an online questionnaire using Google with a WhatsApp link. Informed consent (online) was obtained before enrollment in the study. This study used the DASS-21 questionnaire and a Quality of Life questionnaire for analysis. The total number of participants was 559 during the study period. Descriptive statistics, the non-parametric Chi-square test, the binomial test, the Kruskal-Wallis test, and the Mann-Whitney test were used for analysis. p<0.05 was considered to be statistically significant. Results: Out of 559 respondents, the majority were 21 years of age or older, with a male predominance of 60.6%. It was found that those who were smoking or consuming alcohol had higher DAS scores. Quality of life (QoL) was lower for those who were on medication for hypertension. Stress levels were significantly higher in males. The relationship between anxiety levels and males was statistically significant. Conclusions: COVID-19 had a psychological impact on the medical students. Therefore, early evaluation, timely intervention, and student counseling services need to be made available to solve this problem and remain prepared for all potential future pandemics.